ENSILICATED TECHNOLOGIES LTD
Executive Summary
Ensilicated Technologies Ltd is an early-stage biotechnology company with solid net current assets and cash reserves but increasing short-term liabilities and widening losses. The company’s ongoing viability depends on continued investor support amid typical start-up operating losses. No regulatory compliance issues are evident, but investor due diligence should focus on liquidity management and funding sustainability.
View Full Analysis Report →Who controls this company?
Dr Aswin Doekhie
HISTORIC INFORMATION
- Ceased on
- 2022-07-20
- Correspondence address
- 1 South 1.13, Department Of Chemistry, University Of Bath, Claverton Down, Bath, United Kingdom, BA2 7AY
- Date of birth
- January 1988
- Notified on
- 2022-07-20
- Nature of control
- Owns between 25% and 50% of the company's shares
Dr Asel Sartbaeva
HISTORIC INFORMATION
- Ceased on
- 2022-07-20
- Correspondence address
- 1 South 1.13, Department Of Chemistry, University Of Bath, Claverton Down, Bath, United Kingdom, BA2 7AY
- Date of birth
- September 1977
- Notified on
- 2021-07-29
- Nature of control
- Owns more than 75% of the company's shares
Has more than 75% of the voting rights in the company
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company